Term Name: | EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor |
---|---|
Synonyms: | 3C-like protease inhibitor, 3C-like protease inhibitors, 3cLpro inhibitor, 3cLpro inhibitors, coronavirus 3C-like protease inhibitor, coronavirus 3C-like protease inhibitors, EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitors, EC 3.4.22.69 inhibitor, EC 3.4.22.69 inhibitors, Mpro inhibitor, Mpro inhibitors, SARS 3C-like protease inhibitor, SARS 3C-like protease inhibitors, SARS coronavirus 3CL protease inhibitor, SARS coronavirus 3CL protease inhibitors, SARS coronavirus main peptidase inhibitor, SARS coronavirus main peptidase inhibitors, SARS coronavirus main protease inhibitor, SARS coronavirus main protease inhibitors, SARS coronavirus main proteinase inhibitor, SARS coronavirus main proteinase inhibitors, SARS-CoV 3CLpro enzyme inhibitor, SARS-CoV 3CLpro enzyme inhibitors, SARS-CoV main protease inhibitor, SARS-CoV main protease inhibitors, SARS-CoV Mpro inhibitor, SARS-CoV Mpro inhibitors, severe acute respiratory syndrome coronavirus main protease inhibitor, severe acute respiratory syndrome coronavirus main protease inhibitors |
Definition: | An EC 3.4.22.* (cysteine endopeptidase) inhibitor that interferes with the action of SARS coronavirus main proteinase (EC 3.4.22.69). |
Ontology: | ChEBI [CHEBI:147285] ( EBI ) |